InterCure Ltd. Announces 1-for-5 Reverse Share Split

Strategic Action Aimed at Regaining Compliance with Nasdaq’s Minimum Bid Price Requirement and Protecting Continued Listing Status

NEW YORK and HERTZLIYA, ISRAEL, Aug. 19, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (the “Company” or “InterCure”) (Nasdaq: INCR), today announced that it intends to effect a one-for-five reverse split (the "Reverse Share Split") of the Company’s ordinary shares, no par value per share, (the "Ordinary Shares"). The Ordinary Shares will continue to trade on the Nasdaq Global Market under the existing symbol “INCR”, and will begin trading on a split-adjusted basis when the market opens on August 24, 2026. The new CUSIP number for the Ordinary Shares following the Reverse Share Split will be M549GJ368.